ask="0.4900"
ask_size="1000"
average_daily_volume="1264210"
bid="0.4700"
bid_size="5600"
book_value="-0.1530"
change="-0.0016"
change_from_200_day_moving_average="-0.0163"
change_from_50_day_moving_average="0.0662"
change_from_52_week_high="-1.1646"
change_From_52_week_low="0.2974"
change_in_percent="-0.3285%"
close="0.4854"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.6540"
ebitda="-18.11M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="-0.0900"
eps_estimate_next_year="-0.4500"
ex_dividend_date="N/A"
float_shares="43543000"
high="0.4895"
high_52_weeks="1.6500"
last_trade_date="2/3/2017"
last_trade_price="0.4854"
last_trade_size="393"
last_trade_time="4:02pm"
low="0.4551"
low_52_weeks="0.1880"
market_capitalization="32.87M"
moving_average_200_day="0.5017"
moving_average_50_day="0.4192"
name="BioPharmX Corporation. Common"
notes="N/A"
one_year_target_price="3.0000"
open="0.4870"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-3.2513%"
percent_change_from_50_day_moving_average="+15.8052%"
percent_change_from_52_week_high="-70.5818%"
percent_change_from_52_week_low="+158.1915%"
previous_close="0.4870"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="274.8286"
revenue="119999.00"
shares_outstanding="67719000"
short_ratio="1.1600"
stock_exchange="ASE"
symbol="BPMX"
volume="577707"
weeks_range_52="0.1880 - 1.6500"
